Cant do hot oatmeal but cold protein shake works
Efficacy and safety of the new appetite suppressant, liraglutide: A meta-analysis of randomized controlled trials
165,166 Retatrutide has now entered Phase III clinical trials
Most participants (39.1%) had been using GLP-1RA for over a year
Its not hard to understand why sticking with this regime is challenging a large minority of patients report unpleasant side effects such as nausea and vomiting, and some experience additional side effects such as injection-site reactions, infections, heart burn, and headaches
Results After 3 Months of GLP-1/GIP Medication : Momentum Builds By three months, most people are on a therapeutic dose of medication, and progress becomes more visible